Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Driving Product Development and Finding the Fast Track in Early-Phase Oncology Luke Gill, Peter Larson, and George Hemsworth Your company has received funding for a first-in-man trial of a novel oncology compound. The circumstances are typical: limited budget, uncomfortable ... 2 years ago | 63 mins Direct Oral Anticoagulants for the Treatment of Cancer Associated VTE Dr. Jonathan Sackier About this Webinar This webinar will discuss the increased incidence of venous thromboembolism in cancer patients and the safe and effective use of o... 7 months ago | 71 mins Lean High-volume Hematology Solutions Alan Neal, CSci, MSc, FIBMS, quality manager and lead of specialty, hematology, at Pathology Associates Alan Neal explains how Beckman Coulter’s Lean high-volume hematology solutions can improve laboratory efficiency and help deliver better patient care.... 6 years ago | 65 mins Establishment of a Patient-derived B-ALL Ex Vivo Platform Bandana Vishwakarma, PhD, Scientist in Hematology Oncology at Champions Oncology Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availab... 1 year ago | 23 mins From the Laboratory to Bedside: Expediting Development of Novel Cancer Treatment Collin Hayward and Peter Larson Study of rare cancers poses special challenges for drug developers, who often must draw on their experience in both oncology and rare disease. Current... 2 years ago | 70 mins Principles Of CAR T-Cell Therapy And The Pathway To Regulatory Approval Brian Marks and Ashley Jones For many years, the primary forms of cancer treatment have been chemotherapy, radiation and surgery, but the toughest forms of cancer demand breakthro... 1 year ago | 36 mins Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Stra Colin Hayward and Luke Gill This webcast will review the current state of technology in gene therapeutics and examine trends in immuno-oncology and gene therapy for hematological... 2 years ago | 62 mins 2D Ex Vivo Patient-derived AML Platform for testing Molecular-Targeted Therapies Bandana Vishwakarma, PhD, Scientist in Hematology Oncology at Champions Oncology Champions Oncology was excited to participate in the American Association of Cancer Research’s (AACR) Virtual Meeting in June. Due the limited availab... 2 years ago | 22 mins Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement Neal Goodwin, PhD, Vice President of Research Development Champions Oncology has established an advanced PDX platform for modeling hematology oncology malignancies, including AML and ALL. The resource consist... 2 years ago | 45 mins Innovations in Multivariate Hematology Analysis Gert-Jan van de Geijn, Ph.D. In this on-demand webinar, Dr. Gert-Jan van de Geijn, renowned hematology expert, researcher and industry leader, discusses new chronic obstructive pu... 4 years ago | 51 mins Sepsis Overview: Challenges and Solutions for Laboratories Mirta Gamez, M.T.(A.S.C.P.), C.L.S. Sepsis presents a global healthcare crisis, with more people dying from sepsis than from prostate cancer, colon cancer, breast cancer and AIDS combine... 2 years ago | 51 mins It’s in the blood: Patient-derived hematologic malignancy models in research Amy Wesa, PhD, Director of Immuno-Oncology Research, Champions Oncology Hematological malignancies are cancers that begin in the cells of blood-forming tissue or in the cells of the immune system. These types of cancer, s... 2 years ago | 35 mins Quality Assurance Procedures to Minimize the Lab's Spurious Results Ahmed Bentahar MD, PhD, Senior Manager Global Scientific Marketing, Hematology/Urinalysis, Beckman Coulter When errors pass through laboratory tests undetected, patients may suffer. What if one of the tests your laboratory performs frequently is also the on... 4 years ago | 64 mins Using Hematology Assays to Assess Sepsis Risk Jeannine Holden, M.D., MBA . 2 years ago | 29 mins Rare Disease Research: Conducting Clinical Trials Where the Patients Are Alison Sampson, Hanna Wide, MSc Clinical Trials in Rare Diseases: Where to find Rare Disease Patients Working with sites where the Patients are Supporting the Site Recruitmen... 2 years ago | 47 mins Operational & Regulatory Factors in Cross-Border Enrollment in Rare Disorders Hanna Wide Director, Program Delivery Rare Diseases & Pediatrics at Premier Research Researchers are more focused than ever on finding treatments and cures for rare diseases, encouraged by a regulatory environment that is increasingly ... 1 year ago | 19 mins Microbiology of Gram-negative Bacteria in Cystic Fibrosis Professor Dr. Samantha Sottotetti Learn about the primary pathogens isolated in cystic fibrosis patients and consider these microorganisms’ relative antimicrobial susceptibility. How d... 2 years ago | 20 mins Adjusting Data Parameters to Improve Results and Workflow Dr. Michael Samoszuk How do you know when your result parameters are set to their most efficient ranges? In part two of our three-part webinar series, Dr. Michael Samosz... 5 years ago | 18 mins The Transformational Power of Lean Catherine Oschsner, Danaher Business System Leader The Transformational Power of Lean 8 years ago | 39 mins Urinary Tract Infection (UTI) Screening Using Automated Urinalysis Greg Scott, Sr. Manager Clinical Marketing, Beckman Coulter UTI screening is a valuable and efficient tool for reducing the number of negative urine culture request for possible urinary tract infections. Our d... 8 years ago | 65 mins How Clinical Laboratories Save Money & Help Physicians Become Patient-Centric Jeffrey Reid, Tony McCraney Value-based healthcare policies continue driving the healthcare market away from a fee-for-service model and more toward an enhanced patient managemen... 3 years ago | 30 mins Mean Platelet Volume: An Old New Parameter Dr. Fernando Chaves, Director Global Scientific Affairs In this presentation we will re-visit an often overlooked parameter in the CBC, the MPV. This parameter has critical clinical applications, such as di... 7 years ago | 50 mins The Situation of Antimicrobial Resistance in Europe Professor Gian Maria Rossolini Antimicrobial resistance exhibits remarkable diversity in the European population, providing opportunities to explore both trends and testing. In this... 4 years ago | 26 mins Empowering Oncology Patients to Maximize Study Outcomes Ashley Herrick, Ph.D., Exec. Dir., Oncology Program Strategy & Nicole Carswell, Exec. Dir., Patient Engagement & Recruitment Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughou... February 24, 2022 3:00pm Le volume plaquettaire moyen, un ancien paramètre toujours d'actualité Dr. Fernando Chaves, Director Global Scientific Affairs, Beckman Coulter Dans cette présentation, nous revisiterons un paramètre souvent oublié dans l'hémogramme, soit le volume plaquettaire moyen. Ce paramètre a des applic... 8 years ago | 58 mins Load more
